0
Diffuse Lung Disease: Fellow Case Report Poster - Diffuse Lung Disease II |

Ground Glass Pulmonary Opacities Following Nivolumab Therapy

Hammad Arshad, MD; Meilin Young, MD; Moeezullah Beg, MD; Rajashekar Adurty, MD
Author and Funding Information

Allegheny General Hospital, Pittsburgh, PA


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):500A. doi:10.1016/j.chest.2016.08.514
Text Size: A A A
Published online

Extract

SESSION TITLE: Fellow Case Report Poster - Diffuse Lung Disease II

SESSION TYPE: Affiliate Case Report Poster

PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM

INTRODUCTION: Hypersensitivity Pneumonitis is a rare complication of Nivolumab. We present a rare case of respiratory failure after use of Nivolumab

CASE PRESENTATION: A 56 year old female with past medical history of stage III C breast cancer status post radical modified mastectomy and lymph node dissection presented to our hospital with acute hypoxic respiratory failure. She previously had undergone treatment with different chemotherapeutic agents in addition to radiation for management of recurrent malignant disease. Due to progression of her disease on follow up imaging, patient was started on Nivolumab before her presentation. Workup included a CT angiogram that was negative for pulmonary embolism, but showed stable lymphadenopathy and new bilateral ground glass opacities in the upper lobes left greater than the right. Patient refused to undergo invasive biopsy procedure and was placed on steroids for empiric treatment of hypersensitivity pneumonitis to which she responsed and was discharged home.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543